Explore what causes gastritis, how it’s diagnosed, the different types, and which treatments can help reduce inflammation and ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Alicia and Jon Langenhop's three children were each diagnosed with a rare disorder. A clinical trial was "a no-brainer." ...

A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition ...

Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...

"An exciting finding was when we tried to treat the obese mice with colon inflammation by lowering their inflammation, it actually stopped the ERK pathway in the liver from activating," explains Imai.

As, that fuels belly fat growth in middle age, offering a target for therapies to combat age-related obesity and disease.

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

One man’s waste is Ma Long’s treasure. And in the new-energy era, his map leads to exhausted lithium-ion batteries – veritable troves of reusable resources that are supercharging profits at ...